Arcellx Inc

Arcellx, Inc. is an entity involved in the advancement of novel cellular therapies. Operating primarily within the US, the company provides treatments to a wider global audience, aiming to revolutionise patient care for cancer and autoimmune diseases. Active in the biotechnology sector, Arcellx has a state-of-the-art platform for developing adaptive and controlled cell therapies. While functioning autonomously, the company emphasises partnerships, collaborations, and alliances to accelerate the adoption of its cell therapies. Stay informed and on top of market trends by adding ACLX stock to your eToro watchlist.